Electromed, Inc. (NYSEMKT:ELMD) issued its quarterly earnings results on Tuesday, September 5th. The medical equipment provider reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05, Bloomberg Earnings reports. Electromed had a return on equity of 14.75% and a net margin of 9.71%. The business had revenue of $7.27 million for the quarter.
Electromed (ELMD) opened at 7.4501 on Thursday. Electromed has a 52-week low of $3.38 and a 52-week high of $7.96. The company’s 50 day moving average price is $6.70 and its 200 day moving average price is $5.46. The firm has a market cap of $61.54 million, a PE ratio of 28.6542 and a beta of 0.89.
A number of hedge funds and other institutional investors have recently modified their holdings of ELMD. Tocqueville Asset Management L.P. purchased a new position in Electromed in the first quarter worth about $609,000. Algert Global LLC raised its holdings in Electromed by 382.2% in the first quarter. Algert Global LLC now owns 54,535 shares of the medical equipment provider’s stock worth $269,000 after buying an additional 43,225 shares during the last quarter. Teton Advisors Inc. raised its holdings in Electromed by 11.7% in the first quarter. Teton Advisors Inc. now owns 106,654 shares of the medical equipment provider’s stock worth $526,000 after buying an additional 11,154 shares during the last quarter. Spark Investment Management LLC raised its holdings in Electromed by 47.4% in the first quarter. Spark Investment Management LLC now owns 61,316 shares of the medical equipment provider’s stock worth $302,000 after buying an additional 19,716 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Electromed by 12.2% during the first quarter. Dimensional Fund Advisors LP now owns 143,127 shares of the medical equipment provider’s stock valued at $706,000 after purchasing an additional 15,559 shares during the last quarter.
TRADEMARK VIOLATION WARNING: This article was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://stocknewstimes.com/2017/09/21/electromed-inc-elmd-issues-earnings-results-beats-expectations-by-0-05-eps.html.
Electromed, Inc develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company’s products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others.
Receive News & Ratings for Electromed Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed Inc. and related companies with MarketBeat.com's FREE daily email newsletter.